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Scattering of shorter-wavelength visible light limits the ﬂuorescence imaging depth of thick specimens such as whole organs. In
this study, we report the use of four newly synthesized near-infrared and far-red ﬂuorescence probes (excitation/emission, in
nm: 644/670; 683/707; 786/814; 824/834) to image tumor cells in the subpleural vasculature of the intact rat lungs. Transpelural
imaging of tumor cells labeled with long-wavelength probes and expressing green ﬂuorescent protein (GFP; excitation/emission
488/507nm) was done in the intact rat lung after perfusate administration or intravenous injection. Our results show that the
average optimum imaging depth for the long-wavelength probes is higher (27.8 ± 0.7μm) than for GFP (20 ± 0.5μm; p = 0.008;
n = 50), corresponding to a 40% increase in the volume of tissue accessible for high-resolution imaging. The maximum depth
of cell visualization was signiﬁcantly improved with the novel dyes (36.4 ± 1μm from the pleural surface) compared with GFP
(30.1 ± 0.5μm; p = 0.01; n = 50). Stable binding of the long-wavelength vital dyes to the plasma membrane also permitted in
vivo tracking of injected tumor cells in the pulmonary vasculature. These probes oﬀer a signiﬁcant improvement in the imaging
quality of in situ biological processes in the deeper regions of intact lungs.
Copyright © 2006 Abu-Bakr Al-Mehdi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Physiologists understood early that the study of life is better
in the living than in ﬁxed cells, tissues, or organs. The ulti-
mate question is not what happens in the test tube or in a
frozen moment of time, but what happens kinetically in live
cells in situ. It is now evident that ﬂuorescence imaging tech-
niques of live cells and organs have been and will continue to
be of major help in answering this question.
Using an experimental metastasis model that involves in-
travenous injection of tumor cells in animals, we study the
interaction of tumor cells with the endothelial cells in the
target organ such as the lung and monitor their fate within
and outside the blood vessels. Green ﬂuorescence protein
and ﬂuorescence probes emitting in the 500–600nm range
have been used to label and detect the tumor cells in the pul-
monary circulation in situ [1–3]. With probes in this wave-
length range, there is substantial tissue scattering of both
exciting light and emitted ﬂuorescence. It was demonstrated
that long-wavelength (> 600nm) probes give the best signal
levels in mammalian tissue due to lower absorption in tis-
sue [4]. Scattering in tissues may result from photon inter-
actions with sub-wavelength size structures, such as individ-
ual molecules (Raleigh’s scattering), or from interaction with
supra-wavelength size structures, such as cells, organelles,
and cytoskeleton (Mie scattering) [5, 6]. Raleigh scattering
is inversely proportional to the fourth power of wavelength;
therefore, scattering at 480nm excitation and 510nm emis-
sion for GFP is 6.97 and 6.36 times more than at 780nm ex-
citation and 810nm emission, respectively. Maximum usable
imaging depth in the intact lung is less than 30μmw i t ha
×60 objective and GFP as a ﬂuorophore due to signiﬁcant
limitation of the penetration depth by scattering. The pur-
pose of these studies was to use far-red and near-infrared
ﬂuorescence probes to enhance penetration and increase us-





















































































Figure 1: Normalized excitation (dashed lines) and emission (solid lines) spectra of novel far-red and near-IR ﬂuorescence probes. Spec-
tra of 250nM dye in ethanol were acquired with a Photon Technology International spectroﬂuorometer (R928 PMT; slit width 4nm)
and normalized-to-peak intensity. Peak excitation and emission wavelengths (nm) were PTIR271–644/670; PTIR272–683/707; PTIR273–
786/814; PTIR274–824/834. Small Stokes’ shift and low ﬂuorescence intensity made it diﬃcult to get a complete excitation scan of PTIR274.
Table 1: Characteristics of the far-red and near-infrared ﬂuorescence probes and corresponding Chroma Technologies ﬁlter sets for mi-
croscopy. Bandpass ﬁlter sets Cy5 (for PTIR271) and 41020 (for eGFP) are oﬀ-the-shelf ﬁlters from Chroma Technologies. Sets for PTIR272
toPTIR274were custommanufactured by Chroma.Their names indicate peak excitation/emission wavelengths. FWHM indicates fullwidth
of transmission band at half intensity of maximum transmission.
Peak Filter Excitation ﬁlter Dichroic Emission ﬁlter
Probe excitation/ set Peak transmission/ ﬁlter long Peak transmission/
emission (nm) name FWHM (nm) pass (nm) FWHM (nm)
PTIR271 644/670 Cy5 D640/20 660DCLP D680/30
PTIR272 683/707 680/715 HQ680/20 Q695LP HQ715/30
PTIR273 786/814 780/820 HQ780/20 Q800LP HQ820/30
PTIR274 824/834 800/840 HQ800/20 Q820LP HQ840/30
eGFP 488/507 41020 HQ480/20 Q495LP HQ510/20
imaging in the near-IR and far-red wavelengths is available
oﬀ-the-shelf or is easily made to order, there has been lim-
ited use of any such ﬂuorescent probe in research use for as-
sessing cellular function in an intact organ [7–10]. We have
evaluated four newly developed ﬂuorescent probes of near-
IR and far-red range to test their utility for imaging tumor
cells at greater depths in the intact rat lung. Our results indi-
cate that, compared with GFP, these dyes oﬀer the advantage
of high-resolution imaging of tumor cells at depths greater
than 30μm from the pleural surface of the intact lung. These
vital dyes also appear to be suitable for in vivo tracking of in-
jected tumor cells in the pulmonary vasculature because of
their stable binding to the plasma membrane.
2. MATERIALS AND METHODS
2.1. Fluorescenceprobesandﬁltersets
The vital probes PTIR271, PTIR272, PTIR273, and PTIR274
are membrane-intercalating dyes developed at PTI Research,
I n c .( E x t o n ,P a ) .L i k et h ev i s i b l em e m b r a n ed y e sP K H 2 6a n d
PKH67, the PTIR dyes label cells by partitioning into lipid
regions of cell membranes [11, 12]. However, the PTIR dyes
are both excited and ﬂuoresce in the far-red to near-infrared
region of the spectrum (Figure 1). Spectra were all run on
the HORIBA ﬂuoromax instrument and at settings where
therewasnot signiﬁcant light-scattering artifactforPTIR272
(spectra currently in this ﬁgure were taken on the PTI in-
strument). Based on these spectra, high-quality bandpass in-
terference ﬁlters for use in a Nikon TE2000 inverted wide-
ﬁeld epiﬂuorescence microscope were custom made for the
dyes PTIR272-274 by Chroma Technologies (Rockingham,
Vt) and are described in (Table 1). For PTIR271, the Cy5 ﬁl-
ter set was readily usable.
2.2. Cellsandlabeling
A GFP-expressing murine breast cancer cell line was used
to compare the PTIR dyes with the GFP ﬂuorescence for
tumor cell localization, depth estimation, and image qual-
ity (signal-to-noise ratio). 4T1-GFP cells were trypsinized
from T75 ﬂasks, pelleted and washed with Hanks’ buﬀer, and
then labeled with PTIR dyes at 5μM ﬁnal concentration in
Diluent C (Sigma -Aldrich Chemical Co., St. Louis, Mo) forAbu-Bakr Al-Mehdi et al. 3
5minutes, after which staining was stopped by addition of
serum. The cells were washed again with Hanks’ buﬀer be-
fore being administered in the isolated lung or injected in-
travenously in animals. To assess the eﬀect of the PTIR dyes
on viability, labeling was performed in 35mm Petri dishes.
After washing with Hanks’ solution, viability was assessed by
exclusion of the ﬂuorescent probe propidium iodide, 10μM,
after 30-minute incubation. The cells did not exhibit signs
of loss of viability at 1 or 5μMo fP T I Rd y e s( o n en o n -
viable cell per about 300 cells). FiveμM concentration was
not only nontoxic for these probes, but the resultant ﬂuores-
cence intensity also allowed high-quality imaging of the cells
in the pulmonary vessels of the intact lung, yielding S/N of
greater than 10. Signal-to-noise ratio, a measure of the in-
herent “noisiness” of the region of interest in the picture, was
calculatedbydividingthebackground-subtractedaveragein-
tensity value in the region of interest containing ﬂuorescent
cells by the standard deviation of mean pixel intensity for





An established intact organ microscopy method was utilized
to observe and image subpleural pulmonary vessels in situ in
theisolated,ventilated,blood-freelungsinrealtimeusingan
epiﬂuorescence microscope [1, 13]. In brief, for lung isola-
tion, the animal was anesthetized with intraperitoneal injec-
tion of 60mg/kg body weight sodium pentobarbital. A tra-
cheostomywasperformedandartiﬁcialventilationwith95%
air +5% CO2 was started through a cannula. The abdomen
was opened and the animal was exsanguinated by transec-
tion of major abdominal vessels. A cannula was inserted into
the main pulmonary artery via a puncture in the right ven-
tricle and another was inserted into the left atrium. The lung
was cleared of blood by gravity perfusion via the pulmonary
artery with an artiﬁcial medium (Hanks’ solution with 5%
dextran and 10mM glucose at pH 7.4). The ﬂow-through
perfusate left the lung via the left atrial cannula. Once the
lung became visibly cleared of blood, the heart-lung prepa-
ration was dissected en bloc and was placed in a specially
designed Plexiglas chamber with ports for the tracheal, pul-
monary, and left atrial cannulae. The cardiovascular ports
were connected to a peristaltic pump that recirculated 40ml
of perfusate through the pulmonary vascular bed. The lung
was suspended sideways over a coverslip window at the bot-
tom of the chamber with the posterior surface of the lung
gently touching the coverslip.
The subpleural vasculature of the lungs was directly visu-
alized at high magniﬁcation (×600) by epiﬂuorescence mi-
croscopy. For imaging the morphological and functional dy-
namics of PTIR probe-labeled 4T1-GFP cancer cells in the
subpleural pulmonary circulation, we used a high-resolution
digital ﬂuorescence video microscopy system consisting of a
Nikon TE2000 inverted ﬂuorescence microscope, ×60 wa-
ter immersion (NA is 1.2) and ×60 oil immersion (NA
is 1.4) objectives, automated 10-position ﬁlter wheels for
both excitation and emission (Sutter Instruments, Lambda
10-2), automated dichroic ﬁlter cube changer (Nikon),
xy-axis automated stage (Prior Scientiﬁc, Inc.), z-axis motor
(Prior), a high-resolution, Far-Red and near-IR-sensitive 12-
bitC4742-95-12ERGIEEE1394digitalCCDcamerawithac-
quisition rate of 18frames/s with 2×2 binning (Hamamatsu
Inc.), and MetaMorph image acquisition, processing and
analysis software with 3D reconstruction, and point-spread-
function (PSF) -based deconvolution capabilities (Universal
Imaging Corp., Downingtown, Pa). For 3D reconstruction,
images of the same area were acquired along 40μmo fz-axis
at 0.5μm intervals (optical slicing) over 40seconds. How-
ever, since this was a wideﬁeld ﬂuorescence microscope sys-
tem, there was some out-of-focus light at each of the planes
of acquisition. To eliminate the out-of-focus light, standard
0.1 and 0.5μm ﬂuorescent beads were used as point sources
of light and z-axis image stacks were acquired at 0.5μm in-
tervals for 20μm above and below the plane of sharp focus.
These stacks of images were used by the PSF-based decon-
volution function of the software to calculate and apply the
PSF to the experimental stacks of images for deconvolution.
The deconvolved stacks were then used to create noise-free
3D reconstructions to determine the relationship of the tu-
morcellstotheirsurroundingstructures.Theexcitationlight
source was a 120watt metal halide lamp (X-Cite120, EXFO
Photonics Solutions, Mississauga, ON) with 5% relative out-
put above 600nm. The camera’s CCD is characterized by lin-
ear decrease in quantum eﬃciency from 70% at 450–600nm
to 50% at 700nm, to 30% at 800nm, and to 20% at 850nm.
The PTIR dye-labeled 4T1-GFP cells were either infused
directly into the perfusate of the isolated lungs or injected in-
travenously 3 and 5 days before lung isolation and imaging.
Most of the posterior and lateral aspects of the left lung were
scanned for the deepest-lying cells that could be focused on
in the PTIR dye channels, and the same cells were then im-
aged in the GFP ﬂuorescence channel. The left lung was cho-




Data analysis was done by SigmaStat (SPSS Inc.) using one
way analysis of variance and Bonferroni’s test. Data are ex-
pressed as means ±SE. Diﬀerences were considered signiﬁ-
cant with P < 0.05.
3. RESULTS
The mesothelial monolayer of the visceral pleura is transpar-
ent with UV and visible light excitation/emission. PTIR dye-
labeled 4T1-GFP cells could be readily visualized in the cap-
illaries and pre- and postcapillary vessels of the lungs using
both the GFP ﬁlter set and the appropriate PTIR dye ﬁlter
set (Table 1). Lung tissue did not exhibit detectable autoﬂu-
orescence in the ﬁlter windows used to collect emission from
the PTIR dyes (S/N= 16 ± 0.4; 17.3 ± 0.6; 16.8 ± 0.5; and4 International Journal of Biomedical Imaging
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Figure 2: Increased depth of imaging by using far-red and near-IR probes compared with GFP. 4T1-GFP cells labeled with PTIR271–274
probes were administered in the perfusate of isolated rat lungs or administered in the tail vein followed by lung isolation and intact lung
transpleural imaging. (a) represents GFP picture (Ex/Em 480/510; exposure 0.5s; depth from lung surface 35μm; (b) represents the same
area with PTIR271 picture (Ex/Em 640/680; exposure 0.5s). (c) and (d) represent same area as in (a) and (b), respectively, but with exposure
time of 2 seconds to show the presence of cells in the GFP channel. (e) represents intravascular localization of tumor cell in the GFP channel
5 days after intravenous injection. The vascular outline is visible due to autoﬂuorescence. Exposure time is 2 seconds. Imaging depth is
30μm. (f) represents PTIR271 channel picture of the same area as in (e); exposure time is 0.5 second. (g) and (h) represent pictures in the
GFP and PTIR272 channels, respectively. Exposure time is 2 seconds for GFP; 0.5second for PTIR272. Imaging depth is 30 μm. (i) and (j)
represent pictures in the GFP and PTIR273 channels, respectively. Exposure time is 2seconds for GFP; 0.5second for PTIR273. Imaging
depth is 35μm. (k) and (l) represent pictures in the GFP and PTIR274 channels, respectively. Exposure time is 2seconds for GFP; 0.5second
for PTIR274. Imaging depth is 33μm.
17.5 ± 0.9 for PTIR271, PTIR272, PTIR273, and PTIR274,
respectively versus 12.5 ± 0.6 for GFP; P < 0.05 for all
PTIR probes; n = 4). Decreased light scattering was seen
with the PTIR dyes than with GFP, as expected due to their
longer wavelengths, and was evidenced by increased sharp-
ness and improved edge detection in the PTIR images of tu-
mor cells (Figure 2). The visual quality of pictures was con-
sidered optimum when the S/N was higher than 10. The
depth at which the cell pictures had S/N of more than 10
was deﬁned as the optimum imaging depth. The average op-
timum imaging depth for all of the PTIR dyes was higher
(27.8 ± 0.7μm) than for GFP (20 ± 0.5μm; p = 0.008;
n = 50). The maximum depth at which the cells were still
visible (but with S/N < 10) was signiﬁcantly more for the
PTIR dyes (36.4±1μm) compared with GFP (30.1±0.5μm;
p = 0.01; n = 50). (Figure 3) shows the values of S/N
ratios and imaging depths separately for individual PTIR
probes.
Figure 2 shows representative pictures of PTIR dye-
labeled 4T1-GFP cells lodged in subpleural lung vessels. As
can be readily seen, the long-wavelength probes improve the
sharpness and visibility of cells at depths greater than 30μm.
The PTIR dyes not only improved the quality and depth of
images of cells administered acutely in the isolated lung in
vitro, but they also survived the challenges in vivo for up to
5 days of study (Figures 2(e) and 2(f)). Although the signal
intensity of the PTIR dyes decreased by up to 50% after 5
days in vivo, presumably due to cell division, many tumor
cells were still found to generate higher-quality images in the
PTIR wavelengths than in the GFP wavelength.
4. DISCUSSION
Visualizing biological processes in the living tissue or cells
in situ has always been the goal of ﬂuorescence imaging.






















Figure 3: Signal-to-noise ratio (S/N), maximum imaging depth (Max), and optimum imaging depth (Opt) for GFP and long-wavelength
PTIR dyes. Maximum imaging depth is the distance between the lung surface and the tumor cell in the lung vessels that still can be imaged
using maximum illumination. At optimum imaging depth, high-quality pictures can be obtained with S/N greater than 10. ∗P < 0.05 for all
PTIR probes versus corresponding parameters for GFP.
combination of light sources, optics, detection system, im-
age processing, analysis and acquisition hardware and soft-
ware along with the proper ﬂuorescence probes. The ability
toreconstructthelivingdynamismin3Dandovertimebyz-
axis and time-lapse microscopy has yielded many important
insights into the cell biological processes. An important ap-
proach more recently taken is the ﬂuorescence imaging of
thick living specimens: explant tissues, cells in situ in iso-
lated organs, and whole organisms (e.g., translucent nude
micewithGFP-expressingtumorcolonies)[14–22].Thema-




limiting the depth of visualization. The maximum depth of
imaging allowed by a ×60objective (Nikon PlanApo with a
numerical aperture of 1.4 and a working distance of 210μm)
usingastandard1(1/2)coverslip(170μmthickness)is40μm
into the tissue. GFP and other visible short-wavelength exci-
tation/emission limit the usable depth of imaging to 20μm
due to signiﬁcant scattering and interference caused by aut-
oﬂuorescence.
Using long-wavelength PTIR dyes for imaging intravas-
cular tumor cells in the rat lung instead of GFP increased the
eﬀective depth for high-quality imaging from 20 to 28μm.
This corresponds to a 40% increase in the volume of tissue
accessible for imaging. The increase in maximum imaging
depth from 30 to 36μm results in 20% more sampling vol-
ume. The most signiﬁcant increase in the depth of optimum
imaging was associated with the PTIR271 dye as compared
with GFP. Shifting to longer wavelengths (PTIR272–274) be-
yond that led to only minor improvements in the imaging
parameters in our system, as expected based on the declining
spectral sensitivity of the camera and decreasing light out-
put by the lamp at wavelengths above 700nm. The data pre-
sentedhereinarenotdesignedforcomparativeassessmentof
the eﬃciencies of the probes because of nonuniform detec-
tor sensitivity and illumination. However, our results clearly
show that these dyes are suitable for imaging at their far-red
and near-IR wavelengths using conventional instrumenta-
tion and appropriate ﬁlters. Using these new probes in ad-
dition to GFP, it should be possible to obtain high-quality
images of up to ﬁve distinct colors in a single study, a ca-
pability that will contribute greatly to the goal of being able
to follow biological processes involved in the interactions of
multiple cell types.
Retention of the dyes by the plasma membrane permits
cell tracking in vivo for up to 5 days in our study. Although
permanent expression of GFP or the like is more suitable
for very-long-term in vivo tracking, availability of these new
FR/NIRdyeswillbehelpfulinmulticolorstudies.Theprinci-
ple of dye dilution might help estimate the extent of cell divi-
sion,somethingthatcannotbedonewithGFPalone[11,12].
Furthermore, the better tolerance of FR/NIR excitation by
cells and ﬂuorescent probes due to lower photon energy and
decreased phototoxicity should permit long-term time-lapse
imaging.
5. CONCLUSION
Use of FR/NIR ﬂuorescent probes oﬀers signiﬁcant advan-
tages over blue-green ﬂuorophores for live cell imaging in in-
tact organs. Increased depth of imaging, possibility of mul-
ticolor imaging, and lesser phototoxicity promise better as-
sessment of diﬀerent cellular structure and function by ﬂuo-
rescence microscopy.6 International Journal of Biomedical Imaging
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